Welcome to the CJU website » LOG IN


Hypofractionated radiotherapy with concomitant sunitinib - is there a radiosensitizing effect?
Department of Radiation Oncology, CRCHUM-Centre Hospitalier de l?Universit? de Montr?al ? H?pital Notre-Dame, Montreal, Quebec, Cana
Apr  2009 (Vol.  16, Issue  2, Pages( 4599 - 4600)
PMID: 19364436


Text-Size + 

  • We present a case of a patient with metastatic renal cell cancer (RCC) treated with hypofractionated radiotherapy while being treated with sunitinib. He received a single dose of 8 Gy of external beam radiation to a metastatic mass of several centimeters diameter in the right lateral ribs, followed by a second identical dose. Clinically, the patient achieved a nearly complete disappearance of the mass. We discuss the possible synergy between tyrosine kinase receptor inhibitors (TKRIs) and radiotherapy and the importance of dose fractionation.

Current Issue

October 2021, Vol.28 No.5
canadian journal of urology